InvestorsHub Logo
Followers 13
Posts 4027
Boards Moderated 0
Alias Born 07/14/2016

Re: Keithz post# 42127

Wednesday, 11/08/2017 9:24:18 PM

Wednesday, November 08, 2017 9:24:18 PM

Post# of 108192
30.00 is`nt an option unless 3 of the franchises are worthless. The Lm is far along and very close to the finish line,the rest are not,but have big value potential going forward,so 60.00 is a fire sale number,but one that could be swallowed by everyone,,30 is`nt,because it just does`nt add up. The Lm alone is worth 2-3 billion,right now,IMo,and much more after approval,because it opens the door up for endless partnerships with other approved drugs,in combo. At that point the Lm could be worth double or triple that. If the LM in 6 months can probably fetch 3 billion on it`s own,but Lombardo has Amgn in one pocket,and our other big players in the other. If Amgn is the winner,then 3 billion gets them the NEO,and saves them the milestones owed already,and future revenue profit,already owed to Adxs. Will NEO be a multi billion dollar baby? I say yes,so if Amgn pays 3 billion they get the LM for free,and the Hot,and the HER2,with the Petx money thrown in to cover future accounting costs. Don`t forget everything else Adxs has with our partnerships. This is why I say,even 3 billion is a joke of a buyout for all of Adxs,but if it happens before the Eu approval,,Amgn could get away with one of the biggest thefts in bio history,that`s if Merck or BMY does`nt decide to beat them to the table.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News